Filing Details
- Accession Number:
- 0001562180-19-003161
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-29 16:01:38
- Reporting Period:
- 2019-05-28
- Accepted Time:
- 2019-05-29 16:01:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1597553 | Sage Therapeutics Inc. | SAGE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1042021 | M Jeffrey Jonas | C/O Sage Therapeutics, Inc. 215 First Street Cambridge MA 02142 | President & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-28 | 35,736 | $0.45 | 97,851 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-28 | 25,510 | $173.62 | 72,341 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-28 | 28,293 | $174.48 | 44,048 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-28 | 16,651 | $175.72 | 27,397 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-28 | 11,662 | $176.44 | 15,735 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-28 | 2,545 | $177.62 | 13,190 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-29 | 200 | $169.16 | 12,990 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-29 | 400 | $170.40 | 12,590 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-29 | 475 | $171.39 | 12,115 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-28 | 35,736 | $0.00 | 35,736 | $0.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 91,987 | 2023-08-12 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2011 Stock Option and Incentive Plan. The option fully vested on August 12, 2017.
- This transaction was executed in multiple trades at prices ranging from $172.99 USD to $173.98 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $173.99 USD to $174.93 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $175.05 USD to $176.04 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $176.05 USD to $177.01 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $177.18 USD to $177.98 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $168.82 USD to $169.50 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $170.00 USD to $170.83 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $171.20 USD to $172.00 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
